Please provide your email address to receive an email when new articles are posted on . INDIANAPOLIS — Individuals with mild to moderate presbyopia who were treated with CSF-1 were able to achieve and ...
People with lower kidney function may have higher levels of several blood markers often used in research on Alzheimer's ...
Data represents up to 8.5 years of follow-up and are consistent across age, dose, and genotype BLA resubmitted to U.S. FDA in January 2026; Company expects up to six-month review period per FDA guidel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results